5 States That Could Hold Public Votes on Marijuana Legalization in 2026

As the movement for marijuana legalization continues to gain momentum across the United States, several states are preparing for potential public votes on the issue in 2026.

A number of states are vying to become the 25th to legalize recreational cannabis, including states like New Hampshire, where legalization bills have been advancing in the legislature this session. Among them are several where activists are working to place initiatives on the 2026 ballot. With that in mind, below are the states most likely to see marijuana initiatives put to voters in 2026.

Continue reading

Bill to Expand Marijuana Cultivation Filed in Minnesota House

Minnesota State Representatives Nolan West (R) and Keith Allen (R) have filed legislation that would allow marijuana businesses to significantly expand their cultivation capacity.

House Bill 2426, which has been referred to the Commerce Finance and Policy Committee, would amend state law to increase the allowable plant canopy for licensed medical cannabis combination businesses from 60,000 square feet to 90,000 square feet.

Under the bill, businesses would also be allowed to request canopy increases beyond the new limit by demonstrating market need, compliance with state rules, and cultivation capacity.
Continue reading

Maryland Governor Sent Bill to Legalize Personal Production of Cannabis Concentrates and Expand Resentencing Options

The Maryland Legislature has sent Governor Wes Moore a bill that would legalize the personal production of certain cannabis concentrates while enabling individuals to seek reduced sentences for certain marijuana-related offenses.

Hash (photo credit: WeedMaps).

House Bill 413 and companion measure Senate Bill 925 have officially been sent to Governor Moore, who is expected to sign the measure into law.

“A person who is at least 21 years old may manufacture a personal use amount of cannabis products or concentrated cannabis for personal use or adult sharing at a private residence if the manufacturing process does not involve the use of a volatile solvent,” states the proposed law. In addition to allow production of cannabis concentrates, it would explicitly allow the production of cannabis edibles.
Continue reading

Planet 13 Announces Opening of 32nd Florida Medical Cannabis Dispensary

Planet 13 Holdings Inc., a leading vertically-integrated multi-state cannabis company, today announced the grand opening of its 32nd Florida dispensary in Orange Park on April 4 and 5, 2025.

Located at 921 N Blanding Blvd, Orange Park, FL, the 4,680-square-foot facility is well positioned to serve the medical cannabis community in and around Jacksonville and will be open Monday through Sunday from 9 a.m. to 8 p.m. 365 days a year.

Grand opening celebrations kick-off on April 4, 2025, with local business owners joining the Clay County Chamber of Commerce to cut the ceremonial ribbon at 11 a.m., and guests will be entertained by a popular DJ during the two-day event. A LifeSouth Blood Donation Bus will also be on site along with an MMJ doctor providing information about how to obtain a medical card.
Continue reading

Study: Psilocybin-Assisted Therapy Shows Promise in Treating Fibromyalgia Symptoms

A new pilot study published in the journal Frontiers in Pain Research finds that psilocybin-assisted therapy may offer a safe and potentially effective treatment option for individuals with fibromyalgia.

Dried psilocybin mushrooms.

Researchers from the University of Michigan, The Ohio State University and Johns Hopkins University conducted an open-label clinical trial involving five adults diagnosed with fibromyalgia. Each participant received two doses of psilocybin—15 mg followed by 25 mg—administered two weeks apart, along with preparatory and integration psychotherapy sessions.

The study’s primary focus was on safety. No serious adverse events occurred, though all participants experienced temporary increases in blood pressure or heart rate during dosing, which normalized by the end of treatment. Four participants reported short-term headaches.
Continue reading

Study Finds Sublingual CBD Improves COVID-19 Outcomes

A new peer-reviewed clinical trial conducted by researchers at Tel Aviv University and Reichman University found that sublingual cannabidiol (CBD) may improve clinical outcomes in patients infected with COVID-19.

Published in The Israel Medical Association Journal, the double-blind, placebo-controlled study included 10 participants who tested positive for SARS-CoV-2. Seven patients received CBD extract administered sublingually, while three received a placebo.

Researchers monitored both clinical responses and inflammatory cytokine levels, which are known to play a significant role in the severity of COVID-19 symptoms.

Continue reading

Two Hawaii Senate Committees Approve Bill Allowing Medical Marijuana for Any Condition and Telehealth Evaluations

Two Senate committees in Hawaii have approved legislation that would significantly expand access to medical marijuana and tighten regulations on unlicensed dispensaries.

House Bill 302 was approved today by the Senate Judiciary Committee in a 4 to 1 vote and by the Senate Ways and Means Committee in a unanimous 12 to 0 vote. The measure, filed earlier this month by eight lawmakers, will require one more committee vote before moving to the full Senate.

If passed into law, HB 302 would make several changes to Hawaii’s medical marijuana program. These include allowing physicians and advanced practice registered nurses to certify patients for any condition they deem appropriate for medical marijuana use. Currently, only certain qualifying conditions are permitted under law, such as cancer, epilepsy, multiple sclerosis, PTSD, severe pain, and glaucoma.
Continue reading

U.S. Supreme Court Rules in Favor of Truck Driver Fired for Positive THC Test

The U.S. Supreme Court has ruled in favor of Douglas Horn, a former commercial truck driver who was terminated after testing positive for THC following his use of a hemp-based CBD supplement marketed as containing “0% THC.”

In a 5-4 decision, the court found that individuals can seek damages under the Racketeer Influenced and Corrupt Organizations (RICO) Act for business or property losses stemming from personal injuries. Horn had sued companies including Medical Marijuana Inc., Red Dice Holdings LLC, and Dixie Holdings LLC—makers of the CBD product Dixie X—after he was fired despite relying on the product in good faith.

Horn, who had driven trucks for 14 years, began using Dixie X to relieve pain from a car accident. He said the product’s labeling assured him it was THC-free and compliant with federal law. However, a random drug test led to a positive result and his subsequent dismissal. Horn maintains he never knowingly consumed marijuana.
Continue reading

Oregon: March Marijuana Sales Reach $78 Million, Pushing Total Past $7.4 Billion and Generating $1.25 Billion in Taxes

Oregon’s marijuana industry generated$78 million in sales in March, a notable increase from the $70 million sold in February.

In March, licensed marijuana stores and dispensaries in Oregon sold $78,444,557 worth of marijuana and marijuana products, according to the Oregon Liquor and Cannabis Commission. Although this is a roughly 5% decrease from the $82 million sold in March 2024, the actual amount of cannabis sold is higher, given prices are down over 10%.

In March, Multnomah, by far, was the county with the most sales, at $17.3  million, following by Malheur at $8.5 million, and Washington at $8.4 million. March’s marijuana sales bring the state’s all-time total to above $7.4 billion.
Continue reading

Initiative to Legalize Marijuana Lounges Filed in Oregon, Titled Cannabis Social Lounge Act

A statewide initiative has been filed in Oregon that would legalize cannabis consumption lounges, creating licensed venues where adults could use marijuana in social settings.

The Oregon Cannabis Social Lounge Act (OCSLA), submitted by the Oregon Cannabis Cafe Coalition on March 20, would allow the Oregon Liquor and Cannabis Commission (OLCC) to license cannabis lounges beginning in 2027. These venues would allow on-site consumption but prohibit marijuana sales, requiring patrons to bring their own products.

Under the proposal, which has updated language from a similar initiative the group filed last month, lounges would be limited to microbusinesses and could not be operated by entities holding a retail marijuana license. The initiative also bars the use of alcohol and tobacco on the premises, though lounges would be allowed to sell food, beverages, and hemp-derived CBD products containing no more than 0.3% THC.
Continue reading